# Mercury Chelation to Treat Autism

> **NCT00376194** · PHASE2 · WITHDRAWN · sponsor: **National Institute of Mental Health (NIMH)**

## Conditions studied

- Autism
- Asperger's Disorder
- Child Development Disorders, Pervasive

## Interventions

- **DRUG:** DMSA

## Key facts

- **NCT ID:** NCT00376194
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2006-09
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2013-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00376194

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00376194, "Mercury Chelation to Treat Autism". Retrieved via AI Analytics 2026-08-12 from https://api.ai-analytics.org/clinical/NCT00376194. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*